Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04587752 · ClinicalTrials.gov registry record · NA
Cognitive-Behavioral Therapy for Weight-related Bullying (Online Treatment)
A NA study of Trauma, Psychological and Weight, Body, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04587752: Completed NA study of Trauma, Psychological and Weight, Body, sponsored by Yale University.
NCT04587752 is a NA study of Trauma, Psychological and Weight, Body that has completed, run by Yale University. The registered enrollment target is 30 participants, below the 122-participant average among 14 other Trauma, Psychological trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04587752, a NA study of Trauma, Psychological and Weight, Body, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will perform a clinical trial with adolescents to pilot a new cognitive-behavioral treatment (CBT) for weight-related bullying testing (1) feasibility, (2) acceptability, and (3) initial efficacy. The treatment will be conducted via audio/video telehealth.
Primary Outcome
Reductions in traumatic stress as measured by the Children's Revised Impact of Event Scale (total; scores range from 0 to 65 with higher scores indicative of more traumatic stress)
Conditions Studied
Interventions
- BEHAVIORAL CBT for Weight Bullying
Study Locations (1)
Connecticut
- Yale University School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2023-08-09 |
| Phase | NA |
What the finished NCT04587752 record still lists
NCT04587752 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 122-participant average among 14 other Trauma, Psychological trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Trauma, Psychological appearing as the primary indexed condition, and to 1 intervention - of which CBT for Weight Bullying is the first listed.
NCT04587752 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04587752 about?
NCT04587752 is a clinical study titled "Cognitive-Behavioral Therapy for Weight-related Bullying (Online Treatment)". This study will perform a clinical trial with adolescents to pilot a new cognitive-behavioral treatment (CBT) for weight-related bullying testing (1) feasibility, (2) acceptability, and (3) initial efficacy. The treatment will be conducted via audio/video telehealth.
What is the current status of trial NCT04587752?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-10-05. Estimated completion is 2023-08-09.
What conditions does trial NCT04587752 study?
This clinical trial studies the following conditions: Trauma, Psychological, Weight, Body, Bullying.
What interventions are being tested in trial NCT04587752?
The interventions under investigation include: CBT for Weight Bullying (BEHAVIORAL).
Who is sponsoring clinical trial NCT04587752?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04587752 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma, Psychological
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04587752's enrollment target sits among peer trials
30 14th of 14 higher than 1 of 14 other Trauma, Psychological trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma, Psychological trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Systematic Redesign of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
RECRUITING · NA
-
Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
-
Trauma Intervention to Optimize PrEP Among Women Who Inject Drugs
ACTIVE NOT RECRUITING · NA
-
Accelerated Resolution Therapy for Complicated Grief
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI